BA058 (Abaloparatide) transdermal

abaloparatide · Radius Health, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BA058 (Abaloparatide) transdermal, covering 2016-12-19 to 2016-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis [Phase 2]